Fortis Malar Hospitals Board of Directors
Get the latest insights into the leadership at Fortis Malar Hospitals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Daljit Singh | Chairman (Non - Executive) & Non Independent Direc |
| Mr. Chandrasekar Ramasamy | Whole Time Director |
| Ms. Richa Singh Debgupta | Non Exe.Non Ind.Director |
| Ms. Shailaja Chandra | Independent Director |
| Ms. Suvalaxmi Chakraborty | Independent Director |
| Dr. Ritu Garg | Non Exe.Non Ind.Director |
Fortis Malar Hospitals Share price
FORTISMLR
67.25
0.72 (-1.06%)Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
68.55
Today's Low
67.15
52 Week Low
51.01
52 Week High
98.70
The current prices are delayed, login to your account for live prices
LoginFortis Malar Hospitals FAQs
The board at Fortis Malar Hospitals consists of experienced professionals, including Mr. Daljit Singh , Mr. Chandrasekar Ramasamy , and others, overseeing the company’s strategic and corporate governance.
Directors at Fortis Malar Hospitals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Daljit Singh is the current chairman at Fortis Malar Hospitals.
Executive directors at Fortis Malar Hospitals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Fortis Malar Hospitals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Fortis Malar Hospitals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.